MiNK Therapeutics, Inc. (INKT)
NASDAQ: INKT · Real-Time Price · USD
10.88
-0.26 (-2.33%)
At close: Apr 28, 2026, 4:00 PM EDT
11.10
+0.22 (2.02%)
Pre-market: Apr 29, 2026, 4:00 AM EDT
MiNK Therapeutics Market Cap
MiNK Therapeutics has a market cap or net worth of $54.03 million as of April 28, 2026. Its market cap has increased by 63.72% in one year.
Market Cap
54.03M
Enterprise Value
45.85M
1-Year Change
63.72%
Ranking
Category
Stock Price
$10.88
Market Cap Chart
Since the IPO on October 15, 2021, MiNK Therapeutics's market cap has decreased from $386.36M to $54.03M, a decrease of -86.02%. That is a compound annual growth rate of -35.18%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 28, 2026 | 54.03M | 3.23% |
| Dec 31, 2025 | 52.34M | 89.51% |
| Dec 31, 2024 | 27.62M | -25.23% |
| Dec 29, 2023 | 36.94M | -58.11% |
| Dec 30, 2022 | 88.18M | -40.99% |
| Dec 31, 2021 | 149.43M | -61.32% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| iBio, Inc. | 60.72M |
| MindWalk Holdings | 60.59M |
| Annovis Bio | 60.09M |
| Cue Biopharma | 57.60M |
| Metagenomi Therapeutics | 56.43M |
| Instil Bio | 54.63M |
| Kezar Life Sciences | 54.15M |
| Entera Bio | 52.22M |